About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lung Cancer Clinical Trials | 7,989 Studies Recruiting

Clinical TrialsLung Cancer

Lung Cancer Clinical Trials

Browse 7,989 clinical trials for lung cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2441-2460 of 7,989 trials

CompletedAZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung CancerThis is a phase Ib/II, open-label multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumour activity of AZD9150 plus durvalumab alone or…NCT03421353·Lafayette, Indiana and 5 others TerminatedStudy to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid TumorsThis is a first-in-human, Phase 1, open label, multicenter, multiple dose, dose escalation and dose expansion study intended to evaluate the safety, pharmacokinetic…NCT04628780·Duarte, California and 12 others

Related Searches

nsclctrials sclctrials lung carcinomatrials

Data from ClinicalTrials.govTerms

CompletedAngiogenesis With Positron Emission Tomography (PET) Tracer UptakePurpose: L-\[3-18F\]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for PET.NCT00671242·Showa-machi, Maebashi, Gunma

WithdrawnPersonalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung CancerBoth metastatic squamous non-small cell lung cancer (NSCLC) and extensive stage small cell lung cancer (SCLC) are incurable with current therapies, but due to mutations induced by…NCT03166254

CompletedChemotherapy in Treating Patients With Lung CancerThis observational study was planned, with the primary objective to observe patient survival following first-line treatment of patients of Stage IIIB/IV Non-small Cell Lung Cancer…NCT01067794

TerminatedPh II of Vinflunine and Cetuximab in Second Line Treatment of NSCLCRATIONALE: Drugs used in chemotherapy, such as vinflunine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00519831·Burlington, North Carolina and 1 other

UnknownStudy of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced TumoursThis study is an open, multi-dose, dose escalation and cohort expansion, phase Ⅰ study to investigate the safety, tolerability, efficiency, pharmacokinetics, immunogenicity of…NCT03852823·Shanghai, Shanghai Municipality

CompletedStudy of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for ChemotherapyThis is a Phase II open-label, single-arm, multicenter, international study to evaluate the clinical activity of durvalumab in patients with Stage III unresectable NSCLC who are…NCT04249362·Tucson, Arizona and 34 others

CompletedRadiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain MetastasesRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Gefitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00238251·Bellinzona and 2 others

CompletedHER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung CancerRATIONALE: Vaccines made from the HER2/neu antigen may make the body build an immune response and kill tumor cells.NCT00003002·Seattle, Washington

UnknownPemetrexed/Cisplatin Intercalating Gefitinib Treating EGFR Wild NSCLCTo investigate the curative effect between Pemetrexed/Cisplatin and Pemetrexed/Cisplatin intercalating Gefitinib Treating EGFR Wild NSCLCNCT03374280·Guangzhou, Guangdong

Active not recruitingA Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid TumorsThe purpose of this study is to find out whether the study drug, LY4101174, is safe, tolerable and effective in participants with select advanced or metastatic solid tumors.NCT06238479·Orlando, Florida and 27 others

CompletedLenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR MutationsThe purpose of this study is to assess the safety and efficacy of pemetrexed + carboplatin + pembrolizumab (MK-3475) with lenvatinib (MK-7902/E7080) in patients with advanced…NCT05258279·Chiba, Chiba and 9 others

CompletedIdentification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung CancerThis exploratory study will identify and characterise disorders frequently reported by patients as contributing to or altering their quality of life.NCT06495346·Strasbourg, Grand Est

UnknownRoutine Electronic Monitoring Of Quality Of Life -Poumon (REMOQOL-Poumon)Routine electronic monitoring of health-related quality of life (REMOQOL) consists of collecting HRQoL patients' data via an electronic device in order to provide these data to…NCT04857970·Besançon

Not yet recruitingEvaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance： a Phase II Clinical StudyThis is a Phase II clinical study conducted in China to evaluate the treatment of advanced non-small cell lung cancer with JSKN016.NCT06775483

UnknownMetformin Plus TKI Use in Patients With Non-Small Cell Lung CarcinomaTreatment for patients with mutation in the epidermal growth factor receptor (EGFR) with specific domain tyrosine kinase inhibitors (TKIs) has given place to objective clinical…NCT03071705·México, State of Mexico

UnknownNeoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC PatientsThe purpose of this study is to evaluate the overall response rate and disease free survival for IIIAN2 non-small-cell lung cancer patients with EGFR 19 or 21 exon mutation.NCT01843647·Hangzhou, Zhejiang

TerminatedCabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant MesotheliomaThis study will combine cabozantinib with pemetrexed to treat patients with non-small cell lung cancer, urothelial cancer and advanced malignant mesothelioma.NCT04173338·Augusta, Georgia

TerminatedA Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid TumorsCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT06158958·Duarte, California and 17 others

PreviousPage 123 of 400Next